Have you used oral vancomycin as prophylaxis for C difficile infection in patients admitted for allogeneic hematopoietic cell transplant?
Community PollStarted
How would you manage prophylaxis for C. difficile infection in allogeneic hematopoietic cell transplant patients?
57 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Infectious Disease · National Institute of Allergy and Infectious Diseases (NIAID)
Answered on
Yes, but only in patients with a history of C difficile in the previous year and starting at the time of initiation of broad-spectrum antibiotics (e.g., for fever and neutropenia). We use 125 mg daily.
We are aware this practice may be controversial. To my knowledge, there is only one randomized tria...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Infectious Disease · City of Hope Comprehensive Cancer Center
Answered on
We also use oral vancomycin as secondary prophylaxis for anyone who develops C difficile infection, at a dose of vancomycin 125 mg PO BID, for up to 7 days after concurrent antibiotics are discontinued. This recommendation is based on Morrisette et al., PMID 31255741, a retrospective cohort study of...
Join for free or sign in to see the full answer